Severe infection
Conditions
Interventions
Caspofungin group:None
Omacycline group:None
Imipenem group:None
Sponsors
The Second Affiliated Hospital of Soochow University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Having full capacity for civil conduct and being aged 18 years or older; (2) Being diagnosed with severe infection; (3) Clinically indicated to require the use of antimicrobial agents such as teicoplanin, tigecycline, caspofungin, omadacycline, meropenem, imipenem, and linezolid; (4) Having relevant blood drug concentration monitoring data; (5) Volunteering to participate in the trial and signing the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Pregnant or lactating women; (2) Those who have not used the antimicrobial agents under study or have not undergone blood drug concentration monitoring after using the antimicrobial agents under study; (3) Patients who have not been diagnosed with severe infection; (4) Other circumstances deemed unsuitable for enrollment by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma concentration; | — |
Countries
China
Contacts
Public ContactYu Yunli
The Second Affiliated Hospital of Soochow University
Outcome results
None listed